Mobile

A Phase II, Double-blind, Randomized Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination wi...

Update Il y a 4 ans
Reference: EUCTR2005-003443-31

A Phase II, Double-blind, Randomized Study to Compare the Efficacy of AZD2171 in Combination with 5-fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) and the Efficacy of Bevacizumab in Combination with FOLFOX in the Second-line Treatment of Patients with Metastatic Colorectal Cancer

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Determine the efficacy of AZD2171 in combination with FOLFOX compared to efficacy of bevacizumab in combination with FOLFOX by assessment of PFS

Inclusion criteria

  • Metastatic colorectal cancer

Links